Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > BMS to buy Turning Point Therapeutics for 4.1B$US

<< Previous

Bullboard Posts

Next >>

Comment by lesflicson Jun 03, 2022 1:18pm

231 Views

Post# 34730086

RE:RE:RE:RE:RE:RE:RE:RE:BMS to buy Turning Point Therapeutics for 4.1B$US

What would you like to be when you grow up?

LaserStock29 wrote:

Only get paid for the science that's matured and developed License out rights for other indications = bigger cash upfront NMIBC is probably 2b -3broughly for TLD 1433 Then licensing Ruthenium with ACT for the other indications by Dr.Kaspler 5 of em Lung, brain, head neck, cervical and colon. Get it done by 1Q 2023 and stop f'ing around

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments